Company: HCTI
Filing Date: 2025-03-05
Form Type: PRE 14C
Source: 0001213900-25-020571
Chunk: 4

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-05
Form: PRE 14C
Chunk 4
---
 will not be given an opportunity to vote with respect to the Corporate Actions.
All necessary corporate approvals have been obtained. This Information Statement is furnished solely for the purposes of advising Stockholders
of the action taken by Written Consent and giving Stockholders notice of such actions taken as required by the Exchange Act.

As the Corporate Actions were taken by Written
Consent, there will be no security holders’ meeting and representatives of the principal accountants for the current year and for
the most recently completed fiscal year will not have the opportunity to make a statement if they desire to do so and will not be available
to respond to appropriate questions from our Stockholders.

<div align='center'>2

APPROVAL OF CERTIFICATE OF INCORPORATION AMENDMENT TO EFFECT A REVERSE
STOCK SPLIT OF OUR COMMON STOCK AT A REVERSE STOCK SPLIT RATIO RANGING FROM
1:2 TO 1:250, INCLUSIVE, AS DETERMINED BY OUR BOARD IN ITS SOLE DISCRETION</div>

Reverse Stock Split

The Majority Stockholders approved an amendment
to our Certificate of Incorporation to effect a reverse stock split of our Common Stock at a reverse stock split ratio ranging from 1:2
to 1:250, inclusive, as may be determined at the appropriate time by our Board in its sole discretion (the “Reverse Stock Split”).
This means that our Board will be able to decide whether and when to effect the Reverse Stock Split without further action from the stockholders.

Reasons for a Reverse Stock Split

Maintaining our Listing on Nasdaq

The primary purpose of the Reverse Stock Split
is to raise the per share trading price of our common stock in order to maintain our listing on The Nasdaq Capital Market. Delisting
from Nasdaq may adversely affect our ability to raise additional financing through the public or private sale of our equity securities,
may significantly affect the ability of investors to trade in our securities and may negatively affect the value and liquidity of our
Common Stock. Delisting may also have other negative impacts, including potential loss of employee confidence, the loss of institutional
investors, the loss of analyst coverage or the loss of business development opportunities.

Potentially Improving the Marketability and Liquidity of our Common Stock

The Board believes that an increased stock price
may also improve the marketability and liquidity of our Common Stock. For example, many brokerages, institutional investors and funds
have internal policies that either prohibit them from investing in low-priced stocks or tend